Mixed quinoline derivative iridium (III) complex as well as preparation method and application thereof

A technology of derivatives and complexes, applied in the field of medicine, to achieve the effect of good target inhibition and high anti-tumor activity

Active Publication Date: 2021-04-06
YULIN NORMAL UNIVERSITY
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But there is no iridium metal complex reported by 8-hydroxyquinoline derivatives

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Mixed quinoline derivative iridium (III) complex as well as preparation method and application thereof
  • Mixed quinoline derivative iridium (III) complex as well as preparation method and application thereof
  • Mixed quinoline derivative iridium (III) complex as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] (1) Mixed quinoline derivative iridium (Ⅲ) complex [Ir (3a) (BQ) 2 ] preparation and characterization:

[0040] Such as Figure 6 As shown, weigh compound 4 and compound 3a (8-hydroxyquinoline derivative) according to the molar ratio of 1:1.5, put them into the container, then add ethylene glycol, heat and reflux for 13h under the protection of argon, and obtain a dark red clear solution ; Cool to room temperature, add water to dilute, and then add saturated ammonium hexafluorophosphate solution, which produces a large amount of red precipitate; filter with suction, wash with water and ether, and dry; dissolve the dried crude product with acetonitrile, and filter with neutral alumina Column separation; use V (dichloromethane): V (acetonitrile) = 3: 1 mixed solvent to collect the yellow component, then distill under reduced pressure and spin dry to remove the solvent to obtain a khaki solid product, which is a mixed quinoline derivative Iridium (Ⅲ) complex [Ir (3a) (BQ...

Embodiment 2

[0052] Mixed quinoline derivatives iridium (Ⅲ) complex [Ir (3a) (BQ) 2 ] The synthetic route such as Figure 6 Shown:

[0053] (1) Preparation of Compound 1: Add 600mL of concentrated hydrochloric acid (pre-placed in the refrigerator to freeze, the concentration of concentrated hydrochloric acid is 37% volume fraction) and 14.5g of 8-hydroxyquinoline in a 1L round bottom flask, and heat to 40°C , after the 8-hydroxyquinoline is completely dissolved, add 53g NaClO in batches 3 (The addition was completed within 60 minutes), and after the addition was completed, the stirring was continued at 40° C. for 2 h. After the reaction was completed, dilute to 2L with ice water and dilute with CH 2 Cl 2 (6 × 250mL) extraction, combined organic phase, washed with 3 × 200mL of distilled water, vacuum rotary evaporation of the solvent to obtain a yellow solid, filtered the precipitate, and the solid was recrystallized three times with 40mL of methanol to obtain 6,7-dichloroquinoline-5 ,...

Embodiment 3

[0059] Mixed quinoline derivatives iridium (Ⅲ) complex [Ir (3a) (BQ) 2 ] The synthetic route such as Figure 6 Shown:

[0060] (1) Preparation of Compound 1: Add 725mL of concentrated hydrochloric acid (pre-placed in the refrigerator to freeze, the concentration of concentrated hydrochloric acid is 35% volume fraction) and 14.5g of 8-hydroxyquinoline in a 1L round bottom flask, and heat the temperature to 45°C , after the 8-hydroxyquinoline is completely dissolved, add 64g NaClO in batches 3 (The addition was completed within 60 minutes), and after the addition was completed, the stirring was continued at 45° C. for 1 h. After the reaction was completed, dilute to 2L with ice water and dilute with CH 2 Cl 2 (6 × 250mL) extraction, combined organic phase, washed with 3 × 200mL of distilled water, vacuum rotary evaporation of the solvent to obtain a yellow solid, filtered the precipitate, and the solid was recrystallized three times with 40mL of methanol to obtain 6,7-dichlo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a mixed quinoline derivative iridium (III) complex as well as a preparation method and application thereof, and belongs to the field of medicines. The chemical name of the compound is hexafluorophosphorylate.pyrido [3, 2-a] pyrido [1 ', 2': 1, 2] imidazo [4, 5-c] phenazine. Dibenzoquinoline iridium (III). The preparation method comprises the following steps: reacting 8hydroxyquinoline with hydrochloric acid and NaClO3; adding anhydrous potassium carbonate; adding 2-aminopyridine; adding o-phenylenediamine; obtaining a compound 3a; reacting 7,8-benzoquinoline with iridium trichloride hydrate to obtain a compound 4; and reacting the compound 3a with the compound 4 to obtain the mixed quinoline derivative iridium (III) complex. The in-vitro anti-tumor activity of the compound on a human ovarian cancer drug-resistant strain SK-OV-3/DDP is greater than that of an 8-hydroxyquinoline derivative ligand and a metal-based anti-cancer drug cis-platinum; the toxicity to normal cells HL-7702 is very low, and a good effect of targeted inhibition of human ovarian cancer proliferation is reflected.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a mixed quinoline derivative iridium (III) complex and a preparation method and application thereof. Background technique [0002] Although platinum-based drugs have achieved great success in the clinical application of cancer treatment, platinum-based drugs have the disadvantages of serious toxic side effects and easy drug resistance. Therefore, medicinal chemists have been searching for atypical platinum and non-platinum drugs with high efficacy and low toxicity. 8-Hydroxyquinoline and its derivative metal complexes have attracted extensive interest of medicinal chemistry researchers in recent years due to their strong antitumor activity and diverse action mechanisms. [0003] Quinolines (quinolines) alkaloids are a class of alkaloids with a quinoline ring as the basic nucleus, such as the antimalarial drug quinine and the anticancer drug camptothecin. And 8-hydroxyquinoline...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07F15/00A61P35/00
CPCC07F15/0033A61P35/00
Inventor 杨燕宾贻东廖志强农基健
Owner YULIN NORMAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap